182 related articles for article (PubMed ID: 6735079)
1. Gastric emptying and small intestinal transit in the piebald mouse model for Hirschsprung's disease.
Cooke HJ; Pitman K; Starr G; Wood JD
Gastroenterology; 1984 Aug; 87(2):357-61. PubMed ID: 6735079
[TBL] [Abstract][Full Text] [Related]
2. Centrally administered bombesin affects gastric emptying and small and large bowel transit in the rat.
Porreca F; Burks TF
Gastroenterology; 1983 Aug; 85(2):313-7. PubMed ID: 6862156
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin inhibits gastric emptying and small-intestinal transit in rats and dogs.
Ruwart MJ; Rush BD
Gastroenterology; 1984 Aug; 87(2):392-5. PubMed ID: 6376267
[TBL] [Abstract][Full Text] [Related]
4. Secondary effects of aganglionosis in the piebald-lethal mouse model of Hirschsprung's disease.
Brann L; Furtado D; Migliazzo CV; Baxendale MJ; Wood JD
Lab Anim Sci; 1977 Dec; 27(6):946-54. PubMed ID: 599886
[TBL] [Abstract][Full Text] [Related]
5. Hirschsprung's disease, aganglionic or hypoganglionic megacolon. Animal model: aganglionic megacolon in piebald and spotted mutant mouse strains.
Bolande RP
Am J Pathol; 1975 Apr; 79(1):189-92. PubMed ID: 1124798
[No Abstract] [Full Text] [Related]
6. Electrical and contractile behavior of large intestinal musculature of piebald mouse model for Hirschsprung's disease.
Wood JD; Brann LR; Vermillion DL
Dig Dis Sci; 1986 Jun; 31(6):638-50. PubMed ID: 3709329
[TBL] [Abstract][Full Text] [Related]
7. Upper gut motility of Hirschsprung's disease and its allied disorders in adults.
Tomita R; Ikeda T; Fujisaki S; Shibata M; Tanjih K
Hepatogastroenterology; 2003; 50(54):1959-62. PubMed ID: 14696442
[TBL] [Abstract][Full Text] [Related]
8. Anatomic modifications in the enteric nervous system of piebald mice and physiological consequences to colonic motor activity.
Ro S; Hwang SJ; Muto M; Jewett WK; Spencer NJ
Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G710-8. PubMed ID: 16339294
[TBL] [Abstract][Full Text] [Related]
9. Liquid and solid gastric emptying in adults treated for Hirschsprung's disease during early childhood.
Medhus AW; Bjørnland K; Emblem R; Husebye E
Scand J Gastroenterol; 2007 Jan; 42(1):34-40. PubMed ID: 17190760
[TBL] [Abstract][Full Text] [Related]
10. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists.
Charoenthongtrakul S; Giuliana D; Longo KA; Govek EK; Nolan A; Gagne S; Morgan K; Hixon J; Flynn N; Murphy BJ; Hernández AS; Li J; Tino JA; Gordon DA; DiStefano PS; Geddes BJ
J Pharmacol Exp Ther; 2009 Jun; 329(3):1178-86. PubMed ID: 19252061
[TBL] [Abstract][Full Text] [Related]
11. Transit of a meal through the stomach, small intestine, and colon in normal subjects and its role in the pathogenesis of diarrhea.
Read NW; Miles CA; Fisher D; Holgate AM; Kime ND; Mitchell MA; Reeve AM; Roche TB; Walker M
Gastroenterology; 1980 Dec; 79(6):1276-82. PubMed ID: 7439633
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological analysis of rebound excitation in large intestine of piebald mouse model for Hirschsprung's disease.
Wood JD; Brann LR
Dig Dis Sci; 1986 Jul; 31(7):744-52. PubMed ID: 3720470
[TBL] [Abstract][Full Text] [Related]
13. Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat.
Galligan JJ; Burks TF
J Pharmacol Exp Ther; 1983 Aug; 226(2):356-61. PubMed ID: 6875849
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic cholinergic receptors in the piebald mouse model for Hirschsprung's disease.
Seidel ER; Woods J; Eikenburg BE; Johnson LR
Gastroenterology; 1983 Aug; 85(2):335-8. PubMed ID: 6862158
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic-dependent inhibition of gastric emptying and intestinal motility by fractions of Maytenus ilicifolia Mart ex. Reissek.
Baggio CH; Freitas CS; Mayer B; Dos Santos AC; Twardowschy A; Potrich FB; Cipriani TR; de Souza LM; Sassaki GL; Iacomini M; Marques MC; Mesia-Vela S
J Ethnopharmacol; 2009 Jun; 123(3):385-91. PubMed ID: 19501270
[TBL] [Abstract][Full Text] [Related]
16. Persistence of abnormal gastrointestinal motility after operation for Hirschsprung's disease.
Miele E; Tozzi A; Staiano A; Toraldo C; Esposito C; Clouse RE
Am J Gastroenterol; 2000 May; 95(5):1226-30. PubMed ID: 10811332
[TBL] [Abstract][Full Text] [Related]
17. The mycotoxin, deoxynivalenol, delays gastric emptying through serotonin-3 receptors in rodents.
Fioramonti J; Dupuy C; Dupuy J; Bueno L
J Pharmacol Exp Ther; 1993 Sep; 266(3):1255-60. PubMed ID: 8371135
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory response in enterocolitis in the piebald lethal mouse model of Hirschsprung's disease.
Fujimoto T; Reen DJ; Puri P
Pediatr Res; 1988 Aug; 24(2):152-5. PubMed ID: 3054773
[TBL] [Abstract][Full Text] [Related]
19. Regional effects of hypoxia and hypothermia on rebound excitation in large intestine of piebald mouse model for Hirschsprung's disease.
Wood JD; Brann LR; Daugherty CK
Dig Dis Sci; 1986 Aug; 31(8):859-64. PubMed ID: 3731978
[TBL] [Abstract][Full Text] [Related]
20. Natural history and pathophysiology of enterocolitis in the piebald lethal mouse model of Hirschsprung's disease.
Fujimoto T
J Pediatr Surg; 1988 Mar; 23(3):237-42. PubMed ID: 3357141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
